NEW YORK (GenomeWeb News) – Nanosys and Harvard University have licensed certain patents and patent applications to Vista Therapeutics covering the use of nanowires for biosensors.

Under terms of the license, Louisville, Ky.-based Vista has received exclusive, worldwide rights to use nanowires for detection of biomarkers associated with organ or tissue damage, as well as any form of treatment-associated adverse response. In return, Harvard and Nanosys have received an undisclosed equity stake in Vista, upfront license fees, and will receive downstream royalty payments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in China have generated mouse pups from same-sex parents, according to Scientific American.

Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.

The South China Morning Post reports that Hong Kong plans to add HK$20 billion (US$2.6 billion) to a research endowment.

In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.

Sponsored by

This webinar will address a range of methods for optimizing small RNA library preparation.

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

Sponsored by

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.